Fertility test is a process by which fertility is accessed. The global fertility test market is growing at a significant rate, due to Escalating first-time pregnancy age, introduction of innovative fertility monitors with high-level precision. Different products contributed to the fertility test market size. The market has witnessed high demand for ovulation predictor kits in the coming years due to minimal charge as contrasted to fertility monitors, and less price and high efficiency.
Insight by Product
On the basis of product, the market is subdivided into male fertility testing products, fertility monitors and ovulation predictor kits. Of all products, ovulation predictor kits segment accounted the largest share in the market due to minimal charge as contrasted to fertility monitors, less price and high efficiency, mounting age of first-time pregnancies in women, high preference for these products, effortless OTC obtainability and easiness of usage. The fertility monitor segment is further subdivided into urine-based, saliva-based and others.
Insight by Mode of Purchase
On the basis of mode of purchase, the market is subdivided into prescription-based and non-prescription/OTC-based. Preference of patients towards self-monitoring and remote monitoring, easy availability, and use of fertility and ovulation monitors on e-commerce websites are some of the factors responsible for the growth of the non-prescription/OTC-based fertility tests. Of all the mode of purchase, the non-prescription/OTC-based segment accounted for the largest share in the market.
Insight by Application
On the basis of application, the market is subdivided into female fertility testing and male fertility testing. Declining female fertility rates, elevated price of IVF procedure and accessibility of an extensive range of fertility testing preferences are the factors growing the demand for female fertility testing application. Among all applications, the female fertility testing application accounted for the largest share in the fertility test market.
Insight by End User
The different end users of the market are hospitals, fertility clinics, and others and home care settings. Deterioration of fertility rates in women and men, mounting necessity for constant monitoring of health conditions, and mounting inclination for home and remote monitoring are the factors growing the demand of home care settings. Among all end users, the home care settings accounted for the largest share in the fertility test market.
Mounting acceptance of ovulation monitors based on basal body temperature and effortless accessibility of monitors on e-commerce sites are the trends in the fertility test market.
Escalating first-time pregnancy age, introduction of innovative fertility monitors with high-level precision, deteriorating fertility rates, mounting technological advancement in fertility testing kit and mounting alertness about fertility testing are the primary growth drivers for fertility test market.
Development of conjoined kits for double testing of pregnancy and ovulation and high price and less accuracy of IVF treatment is also facilitating the growth for the fertility test market.
The high price of fertility testing monitors, untested precision of urine-based ovulation monitors and reduced precision of ovulation prediction kits are the major challenges for the growth of fertility test market.
Globally, the manufacturing companies trying to enter the fertility test market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest fertility test market as in the region the usage of a fertility monitoring device for contraception is increasing.
Escalating first-time pregnancy age, mounting awareness about the benefits of ovulation monitors through social media, e-commerce sites, and marketing campaigns, and mounting occurrence of polycystic ovary syndrome are also up surging growth of the North American fertility test market. For instance, according to the Centre for Disease Control and Prevention (CDC) report on National Vital Statistics Report 2015, in the U.S., the mean age of mother at first birth was 25.8 years in 2012, and it has increased to 26 years in 2013.
Asia-Pacific is observed to witness the fastest growth in the market, due to mounting occurrence of lifestyle disorders. In addition, mounting funding for the improvement of fertility and ovulation monitors and the mounting number of manufacturers and suppliers of fertility testing is also creating a positive impact on the fertility test market growth in the region.
Key players in the fertility test market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In December 2016, Prestige Brands Holdings, Inc. has entered into a definitive agreement to acquire C.B. Fleet Company, to enhance its product portfolio in feminine care and other over-the-counter healthcare products.
In July 2016, Ava launched Ava Bracelet, a fertility tracking sensor bracelet, to detect the fertility days during a women’s cycle. Advacare Pharma, Biozhena, Fertility Focus, Prestige Brands Holdings, AVA, SPD Swiss Precision Diagnostics, Fairhaven Health, Taidoc, Babystart, Hilin Life Products, Church & Dwight, Sensiia and Geratherm Medical are the key players offering fertility test.